Secondary Recommendation

Healthcare Enterprise Group - Decontamination product a potential blockbuster

January 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

In spite of its oddly low price, which will soon be rectified by a 1for 25 share consolidation, Healthcare Enterprise, 2.36p, (market cap: Â£80m) is attracting a substantial institutional following, Fidelity being the latest to appear on its register with a 3.4% holding. Healthcare Enterprise's mainstay is the distribution of first aid kits and occupational health products to the corporate sector, a strongly cash generative business which is going from strength to strength. However, the reason the shares are posting new highs is due to the excitement resulting from two products in the research division which have the ingredients to become company makers; one is a decontaminationagent to counter MRSA infection in hospitals, the othe ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Goals Soccer Centres - Exciting new issue rapidly rolling out 5-a-side soccer centres

Majestic Wine

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X